Clinical Trial Update: VitD3 Supplementation in Patients With Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early trial evaluating Vitamin D3 (cholecalciferol) supplementation in patients with multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Amany Keruakous, MD, MS. | Conditions: Multiple Myeloma | EARLY_Phase 1 | Status: RECRUITING